Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong · Delayed Price · Currency is HKD 4.100
-0.050 (-1.20%)
Sep 18, 2026, 3:55 PM HKT
HKG:2563 Market Cap
HKG:2563 has a market cap or net worth of 1.49 billion as of September 18, 2026. Its market cap has decreased by -52.44% in one year.
Market Cap
1.49B
Enterprise Value
980.45M
Revenue
63.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.10
ChartMarket Cap Chart
Since October 31, 2024, HKG:2563's market cap has decreased from 7.58B to 1.49B, a decrease of -80.29%. That is a compound annual growth rate of -57.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.49B | -16.16% |
| Dec 31, 2025 | 1.78B | -75.18% |
| Dec 31, 2024 | 7.18B | -5.29% |
| Oct 31, 2024 | 7.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AIM Vaccine | 1.94B |
| HighTide Therapeutics | 1.79B |
| Guangzhou Innogen Pharmaceutical Group | 1.75B |
| Mabpharm | 1.73B |
| SinoMab BioScience | 1.59B |
| Shandong Boan Biotechnology | 1.59B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.37B |
| Zhaoke Ophthalmology | 1.36B |